KPRX · Company research
Kiora Pharmaceuticals, Inc. Common Stock (KPRX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 2.53 | $16,494,402.93 | 9417869.93 | 2.9195402298850575 | — | — | 12.3436800465177888 | 0.97850787482642647082 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.